BioCentury
ARTICLE | Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones

February 24, 2014 8:00 AM UTC

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) rose $1.21 (24%) to $6.16 on Wednesday after FDA granted accelerated approval to Northera droxidopa to treat neurogenic orthostatic hypotension (NOH). The company plans to launch Northera next half.

Chelsea finished the week up $1.31 (28%) to $6.04...